Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CardioTech expands heart bypass graft trial:

This article was originally published in Clinica

Executive Summary

CardioTech is expanding the feasibility trial of its coronary artery bypass graft, following the recent positive results of its first few patients. The Woburn, Massachusetts firm plans to implant 20 patients with the CardioPass graft, as part of its trial, which is being conducted in Brazil and Chile. The graft is made of microporous polyurethane, designed to be kink resistant. CardioTech is one of only two firms - the other Pleasanton, being California-based Thoratec - pursuing clinical trials of a synthetic artery bypass graft, which will target a potential market believed to be worth $1.5bn annually.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063895

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel